DNSMX Mutual Fund

DNSMX Mutual Fund

NAV$27.79
See how much of DNSMX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing the top 10 of 123 holdings · as of Aug 31, 2026
Top 10 weight
17.28%
DNSMX top 10 holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
GH
Guardant Health, IncHealth Care · Biotechnology
2.33%
2.3%231,832$36.87MHealth CareBiotechnology
2
PRAX
Praxis Precision Medicines IncHealth Care · Biotechnology
2.02%
4.3%91,568$32.08MHealth CareBiotechnology
Sector and industry · Pro
3
SYRE
Spyre Therapeutics Inc
1.89%
6.2%335,510$29.97M
4
FROG
Jfrog Ltd
1.67%
7.9%265,074$26.53M
5
BGSXX
Northern Inst Fds Govt Select Pt
1.66%
9.6%26,257,807$26.26M
6—Definium Therapeutics, Inc. Common Shares
1.62%
11.2%646,000$25.66M
7
TWST
Twist Bioscience Corp.
1.56%
12.7%178,148$24.76M
8—Xenon Pharmaceuticals Inc
1.54%
14.3%403,823$24.32M
9
ZETA
Zeta Global Holdings Corp-A
1.50%
15.8%766,878$23.75M
10
EWTX
Edgewise Therapeutics Inc.
1.49%
17.3%566,690$23.67M
More holdings · Pro
FundXLS Pro
See the other 113 holdings of DNSMX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime
Themes in the top 10
Digital HealthBiotechnologyLife Sciences ToolsPharmaceuticalsBiotechnology ToolsImmunologyOncologyHealth & WellnessEmerging TechArtificial IntelligenceAging PopulationData & AnalyticsDigital AdvertisingInternet & DigitalCloud Computing

DNSMX Mutual Fund Top Holdings

DNSMX holdings top 10 positions. The top 10 holdings account for 17.3% of the fund, led by Guardant Health, Inc at 2.3%, Praxis Precision Medicines Inc Common Stock Usd.0001 at 2.0%, Spyre Therapeutics Inc at 1.9%.

DNSMX portfolio concentration is well-diversified, with the top 10 representing 17.3% of total assets. The largest sector exposure is Health Care at 28.7%.

DNSMX sectors provide a detailed breakdown. DNSMX overlap shows how holdings compare to other funds in your portfolio.